» Articles » PMID: 27363737

Quantitative Real-time PCR Assays for Detection and Type-specific Identification of the Endemic Species C Human Adenoviruses

Overview
Journal J Virol Methods
Specialty Microbiology
Date 2016 Jul 2
PMID 27363737
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Human adenoviruses (HAdVs) are medically important respiratory pathogens. Among the 7 recognized species (A-G), species C HAdVs (serotypes 1, 2, 5 and 6) are globally endemic and infect most people early in life. Species C HAdV infections are most often subclinical or mild and can lead to persistent shedding from the gastrointestinal and upper respiratory tracts. They can also cause severe disseminated disease in newborn and immunocompromised persons, where rapid and quantitative detection and identification of the virus would help guide therapeutic intervention. To this end, we developed quantitative type-specific real-time PCR (qPCR) assays for HAdV-1, -2, -5 and -6 targeting the HAdV hexon gene. All type-specific qPCR assays reproducibly detected as few as 5 copies/reaction of quantified hexon recombinant plasmids with a linear dynamic range of 8 log units (5-5×10 copies). No non-specific amplifications were observed with concentrated nucleic acid from other HAdV types or other common respiratory pathogens. Of 199 previously typed HAdV field isolates and positive clinical specimens, all were detected and correctly identified to type by the qPCR assays; 10 samples had 2 HAdV types and 1 sample had 3 types identified which were confirmed by amplicon sequencing. The species C HAdV qPCR assays permit rapid, sensitive, specific and quantitative detection and identification of four recognized endemic HAdVs. Together with our previously developed qPCR assays for the epidemic respiratory HAdVs, these assays provide a convenient alternative to classical typing methods.

Citing Articles

An Old Acquaintance: Could Adenoviruses Be Our Next Pandemic Threat?.

Saint-Pierre Contreras G, Conei Valencia D, Lizama L, Vargas Zuniga D, Avendano Carvajal L, Ampuero Llanos S Viruses. 2023; 15(2).

PMID: 36851544 PMC: 9966032. DOI: 10.3390/v15020330.


Human adenovirus species in children with acute respiratory illnesses.

Probst V, Datyner E, Haddadin Z, Rankin D, Hamdan L, Rahman H J Clin Virol. 2020; 134:104716.

PMID: 33360858 PMC: 8324062. DOI: 10.1016/j.jcv.2020.104716.


Perspective on Adenoviruses: Epidemiology, Pathogenicity, and Gene Therapy.

Crenshaw B, Jones L, Bell C, Kumar S, Matthews Q Biomedicines. 2019; 7(3).

PMID: 31430920 PMC: 6784011. DOI: 10.3390/biomedicines7030061.


Comparative evaluation of a laboratory-developed real-time PCR assay and RealStar® Adenovirus PCR Kit for quantitative detection of human adenovirus.

Wong S, Yip C, Sridhar S, Leung K, Cheng A, Fung A Virol J. 2018; 15(1):149.

PMID: 30261891 PMC: 6161464. DOI: 10.1186/s12985-018-1059-7.

References
1.
Ebner K, Rauch M, Preuner S, Lion T . Typing of human adenoviruses in specimens from immunosuppressed patients by PCR-fragment length analysis and real-time quantitative PCR. J Clin Microbiol. 2006; 44(8):2808-15. PMC: 1594637. DOI: 10.1128/JCM.00048-06. View

2.
McCarthy T, Lebeck M, Capuano A, Schnurr D, Gray G . Molecular typing of clinical adenovirus specimens by an algorithm which permits detection of adenovirus coinfections and intermediate adenovirus strains. J Clin Virol. 2009; 46(1):80-4. PMC: 2846087. DOI: 10.1016/j.jcv.2009.06.008. View

3.
Cassir N, Hraiech S, Nougairede A, Zandotti C, Fournier P, Papazian L . Outbreak of adenovirus type 1 severe pneumonia in a French intensive care unit, September-October 2012. Euro Surveill. 2014; 19(39). DOI: 10.2807/1560-7917.es2014.19.39.20914. View

4.
Adrian T, Wadell G, Hierholzer J, Wigand R . DNA restriction analysis of adenovirus prototypes 1 to 41. Arch Virol. 1986; 91(3-4):277-90. DOI: 10.1007/BF01314287. View

5.
Madisch I, Wolfel R, Harste G, Pommer H, Heim A . Molecular identification of adenovirus sequences: a rapid scheme for early typing of human adenoviruses in diagnostic samples of immunocompetent and immunodeficient patients. J Med Virol. 2006; 78(9):1210-7. DOI: 10.1002/jmv.20683. View